Trial
NCT00253721
Melphalan With BBBD in Treating Patients With Brain Malignancies
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
OHSU Knight Cancer Institute
Collaborators
National Cancer Institute (NCI)
Condition
Brain and Central Nervous System Tumors
Intervention
Melphalan
Why stopped
Other competing clinical trials affecting enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-21